# Euclidean Capital: portfolio, investments and team

> Euclidean Capital is a family office based in United States. 11 investments on record, 3 in the last 12 months, latest Oct 2026.

Source: https://millionrounds.com/fund/euclidean-capital (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Euclidean Capital

Last cheque observed Oct 2026; 11 cheques on record.

Email

Deploying now Family office

Buyout Growth Seed Food And Beverage Social Impact Sustainability

Follow Euclidean Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Feuclidean-capital)

Deploying now

**100%** of best year **3** **cheques in 12 months**, 11 on record

Since the last cheque **1** days **00** hrs **00** min **00** sec

Median round **$65M** Rounds led **0 of 11** Mostly in **United States, 100%**

Pitch Euclidean Capital

## Euclidean Capital highlights

- 01 3 cheques in the last 12 months
- 02 Mostly Series B and Series A: 50% of its rounds

## What they do

- **Type:** Family office (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Buyout Growth Seed Series A Series B
- **Sectors:** Food And Beverage Social Impact Sustainability
- **Based in:** Houma, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **11 appearances**

- **2026** 2 rounds
- **Oct** **[Setara Biosciences](https://millionrounds.com/company/setara-biosciences)** Series A · US · Pulse 2.0 **$90M** With 6 others
- **Sept** **[Savvy Wealth](https://millionrounds.com/company/savvy-wealth)** Series C · US · Ventureburn **$100M** With 9 others
- **2025** 3 rounds
- **Dec** **[Ripple Foods](https://millionrounds.com/company/ripple-foods)** US · AlleyWatch **$17M** With 9 others
- **Aug** **[SetPoint Medical](https://millionrounds.com/company/setpoint-medical)** Series D · US · Elevage Medical Technologies **$140M** With 17 others
- **Mar** **[Zeitview](https://millionrounds.com/company/zeitview)** Growth · US · Energy Transition Ventures **$60M** With 9 others
- **2019** 3 rounds
- **Nov** **[PMV Pharma](https://millionrounds.com/company/pmv-pharma)** Series C · US · Prweb **$62M** With 7 others
- **Nov** **[BuildOPs](https://millionrounds.com/company/buildops)** Seed · US · TechCrunch **$5.8M** With 12 others
- **Oct** **[ArsenalBio](https://millionrounds.com/company/arsenalbio)** Series A · US · FinSMEs **$85M** With 6 others
- **2018** 3 rounds
- **Dec** **[Kallyope](https://millionrounds.com/company/kallyope)** Series B · US · FinSMEs **$21M** With 6 others
- **Feb** **[Kallyope](https://millionrounds.com/company/kallyope)** Series B · US · FinSMEs **$66M** With 6 others
- **Jan** **[Ribon Therapeutics](https://millionrounds.com/company/ribon-therapeutics)** Series B · US · Marketwatch **$65M** With 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **11** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

- **Legal name:** Ardinall Investment Management LP
- **SEC number:** CRD 298114

## The cheque

Buyout Growth Seed

Median round joined **$65M** the round, not its cheque

Led 0 of 11 rounds **0%**

- **Sole investor:** Never alone
- **Last cheque:** Oct 2026

Rounds by stage said on their site

- Series B said *3*
- Series A said *2*
- Series C *2*
- Growth said *1*
- Seed said *1*
- Series D *1*
- Buyout said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Osage University Partners](https://millionrounds.com/fund/osage-university-partners) 3
- [The Column Group](https://millionrounds.com/fund/the-column-group) 3
- [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 2
- [Deerfield](https://millionrounds.com/fund/deerfield) 2
- [Goldbell Group](https://millionrounds.com/fund/polaris) 2
- [Illumina](https://millionrounds.com/fund/illumina) 2

**Pitching Euclidean Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Euclidean Capital. A count of rooms they were both in, not a relationship either has claimed.

[**Osage University Partners** VC firm **3** rounds together](https://millionrounds.com/fund/osage-university-partners)[**The Column Group** VC firm **3** rounds together](https://millionrounds.com/fund/the-column-group)[**Alexandria Real Estate Equities** VC firm **2** rounds together](https://millionrounds.com/fund/alexandria)[**Deerfield** VC firm **2** rounds together](https://millionrounds.com/fund/deerfield)[**Goldbell Group** Growth equity **2** rounds together](https://millionrounds.com/fund/polaris)[**Illumina** Company **2** rounds together](https://millionrounds.com/fund/illumina)[**Two Sigma** VC firm **2** rounds together](https://millionrounds.com/fund/two-sigma)[**Viking Global** VC firm **2** rounds together](https://millionrounds.com/fund/viking-global-investors)

## Recently backed

The latest companies Euclidean Capital put money into.

[**Savvy Wealth** $100M · Sept 2026](https://millionrounds.com/company/savvy-wealth)[**Ripple Foods** $17M · Dec 2025](https://millionrounds.com/company/ripple-foods)[**SetPoint Medical** $140M · Aug 2025](https://millionrounds.com/company/setpoint-medical)[**Zeitview** $60M · Mar 2025](https://millionrounds.com/company/zeitview)[**BuildOPs** $5.8M · Nov 2019](https://millionrounds.com/company/buildops)[**ArsenalBio** $85M · Oct 2019](https://millionrounds.com/company/arsenalbio)

## Mentioned on podcasts

Episodes that name Euclidean Capital in their description, not their title.

- [Capital Allocators](https://millionrounds.com/podcasts/capital-allocators) 4 Jul 2022 · 1h 4m Ashvin Chhabra – The Aspirational Investor (Capital Allocators, EP.260) Mentions [Euclidean Capital](https://millionrounds.com/fund/euclidean-capital)[Merrill Lynch](https://millionrounds.com/fund/merrill-lynch)[Jim Simons](https://millionrounds.com/person/jim-simons) Apple PodcastsShow page

## Quick answers about Euclidean Capital

### What does Euclidean Capital invest in?

Euclidean Capital invests most often at Series B and Series A (50% of the rounds on record), in sectors such as Food And Beverage, Social Impact and Sustainability.

### How active is Euclidean Capital?

11 investments on record, 3 of them in the last 12 months. The most recent was in Oct 2026.

### What has Euclidean Capital invested in recently?

Its most recent investments on record: Setara Biosciences (Series A, Oct 2026), Savvy Wealth (Series C, Sept 2026) and Ripple Foods (Dec 2025).

### How big are Euclidean Capital's cheques?

The median round it joins is $65M.

### Does Euclidean Capital lead rounds?

Rarely, if at all: none of its 11 investments on record names it as the lead.

### Where does Euclidean Capital invest?

Most of the companies it backs are in the United States (100%).

### Is Euclidean Capital investing now?

Yes: it is actively investing, with 3 investments in the last 12 months.

### Who does Euclidean Capital invest alongside?

Most often Osage University Partners (3 rounds together), The Column Group (3 rounds together) and Alexandria Real Estate Equities (2 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=euclidean-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=euclidean-capital)
